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Balloon expandable stent-graft allows to treat short/no necks AAA:
initial experience of a new balloon expandable bifurcated stent graft.
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Pierre Julia (2), Marc Sapoval (1)
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Pompidou (HEGP), Chirurgie Vasculaire, Paris, France – (3) Hôpital
Européen Georges Pompidou, Médecine Vasculaire (HEGP), Paris,
France
Purpose: To report initial experience with the SETA balloon expandable
stent graft to treat abdominal aorta aneurysm (AAA). This stent graft is
designed to accommodate very short infra-renal neck because the balloon
allows sealing of non cylindrical and/or dilated infra renal aorta.
Methods: We treated 8 consecutive patients (mean age 77 years ; 8 male)
for AAA with no or short neck with a SETA stent graft (6 bifurcated, 1 aorto-
uniliac, 1 bifurcated with renal branch). None of these patients were eligible
for endovascular repair with conventional stent-grafts. Mean aneurysm dia-
meter was 56,7mm [45mm-67mm] (anteroposterior ; DAP) and 65.9mm
[52mm-74mm] (transverse ; DTR). Mean length of the infrarenal neck was
1.8mm [0mm-8mm]. Patients were followed by repeated CTA and clinical
consultation.
Results: All patients underwent successful implantation. One month mor-
tality and morbidity was 0%. CT at discharge showed no residual endoleak.
Mean follow-up was 8.2 months. CT at last follow-up showed DAP=-2.7 mm
[45-63] and DTR=+1.5 mm [52-86] (p=0.25 ; p=0.83 respectively). In no
case, AAA showed increase of diameter (threshold 4mm). In one patient, a
secondary type I endoleak was treated unsuccessfully by additional balloon
expandable tube graft.
Conclusion: Balloon expandable SETA graft showed encouraging initial
results in patients with unfavorable anatomy for conventional aortic stent
grafts.
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A face-to-face comparison of 5 scores to predict mortality during sur-
gical aortic valve replacement for aortic stenosis: all good but perfec-
tible.
Emmanuelle Begot (1), Victor Aboyans (2), Dania Mohty (1), Marc
Laskar (3), Patrice Virot (1)
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Background: The decision for referral to surgery for severe aortic stenosis
(AS) is conditioned by the pre-operative risk stratification. We analyzed the
validity of five risk scores in cardiac surgery, in the specific setting of isolated
surgical aortic valve replacement (SAVR). 
Methods: We reviewed the files of all patients who underwent isolated
SAVR in our institution from 01/2005 to 12/2010. The 30-days mortality was
compared with the mortality risk predicted by the following scores: Additive
Euroscore (AddEu), Logistic Euroscore (LogEu), New Euroscore (NewEu),
the STS and the Ambler score. Scores validity were assessed through the dis-
crimination provided by the area under the ROC curve (AUC) and the calibra-
tion provided by the comparison between predicted mortality and observed
mortality in different levels of risk. 
Results: We studied 507 patients (age 72.9±10.2 yrs). The 30-days
observed mortality was 3.1%, while the mortality predicted by AddEu, LogEu,
NewEu, STS and Ambler scores was 7%, 6.1%, 1.6%, 2.1%, and 3% respec-
tively. The discrimination was satisfactory, with an AUC above 0.75 for the
5 scores, without any significant difference among them (Figure). However,
all the 5 scores presented poor calibration. Using a logistic regression model,
we created a new simple score with 4 preoperative variables: atrial fibrillation,
heart failure, cerebrovascular disease, and 2+ mitral regurgitation. The post-
hoc AUC obtained by this score was at 0.87 (IC95%: 0.84-0.90). 
Conclusion: Despite a good discriminative value, these 5 risk scores lack
for calibration in case of isolated SAVR. They cannot substitute the clinical
judgment during the heart team discussion for the therapeutic choice for AS.
We propose a new and simple score, which requires further external valida-
tion.
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Toward a surgical management of type B aortic dissection?
Salma El Batti (1), Jean-Marc Alsac (1), Marwan Abou-Rjeili (1), Tristan
Mirault (2), Emmanuel Messas (2), Pierre Julia (1), Jean-Noël Fabiani (1)
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Background: Aortic type B dissection is classically managed medically.
However, more and more benefit of surgical or interventional procedures for
visceral complications mangement. The goal of our study was to evaluate the
impact of acute type B aortic dissection management by a surgical team
Methods: From 2005 to 2012, all patients treated for acute type B aortic
dissection were retrospectively reviewed. Two treatment protocols were com-
pared: before 2009, initial management was conducted in Intensive Care Unit
of Cardiology; at 2009 and after, patients were treated in a protocol for
receiving aortic emergencies (SOS Aorte) managed by vascular surgeons. In
cases of imminent rupture, organ malperfusion, aortic diameter ≥40 mm, per-
sistent pain or uncontrolled renovascular hypertension, surgical treatment was
mandatory
Results: 87 patients were supported for acute type B aortic dissection
(70.1% men, mean age 64±11). 33 patients (37.9%) received medical treat-
ment alone, and 54 patients (62.1%) required additional surgical treatment:
malperfusion (n=21), uncontrolled hypertension (n=18), rupture (n=9), persis-
tent pain (n=4), aorta ≥40 mm (n=2). Overall mortality was 9.2%. 4 patients
presented major postoperative complications: bowel ischemia (n=3), tempo-
rary dialysis (n=2), stroke without sequelae (n=1). Of the 26 patients treated
before 2009, 14 were operated (53.8%): 11 thoracic stentgrafts. Of the
61 patients treated after 2009, 40 were operated (65.6%): 33 thoracic stent-
grafts (12 associated with a non-covered aortic extension stent, and 7 with a
January 18th, Saturday 2014
100
80
60
40
20
0
0 20 40 60 80 100
Se
ns
it
iv
it
y
1-Specificity AddEu
LogEu
NewEu
STS
Ambler
Figure – ROC curves of the 5 predictive scores
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peripheral stenting), 5 peripheral spot stenting alone, 3 fenestrations, and 1
aortic tube. In-hospital mortality was 15.4% before 2009, and 6.6% after.
Conclusions: In our experience, initial management of acute type B aortic
dissection by vascular surgeons appeared to improve in-hospital survival, at
the cost of more interventional procedures. The long-term benefit of this treat-
ment on the natural history of dissections remains to be evaluated.
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Bilateral versus unilateral internal mammary revascularization in
patients with left ventricular dysfunction: long-term clinical outcomes
in a consecutive series of 430 patients
Batric Popovic (1), Damien Voilliot (1), Yves Juillière (1), Nicolas Dan-
chin (2), Pablo Maureira (3), Fabrice Vanhuyse (3), Etienne Aliot (1), Jean
Pierre Villemot (3)
(1) CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, France –
(2) Hôpital Européen Georges Pompidou (HEGP), Cardiologie, Paris,
France – (3) CHU Brabois, Chirurgie cardiovasculaire, Vandoeuvre Les
Nancy, France
Background: Left ventricular ejection fraction (LVEF) is a recognized
determinant of survival in patients with coronary artery disease.
The survival benefit of bilateral internal mammary artery (BIMA) grafts
compared with left internal mammary artery (LIMA) with additional saphe-
nous venous grafts (SVG) is still debated in this situation.
Methods and Results: Between 1996 and 2009, we performed elective, iso-
lated, primary, multiple CABG in 430 consecutive patients with LVEF≤40%.
The early and long-term results were compared between 167 patients under-
going BIMA grafting and 263 patients using LIMA-SVG.
The mean age of the overall population was 60±15 years. In-hospital mor-
tality was not different between the two groups (7.8% vs 10.6%, p=ns). Early
postoperative morbidity included myocardial infarction (4.2% vs. 4.2%, p=ns),
stroke (1.2% vs 3.4%, p=ns), and mediastinitis (5.4% vs 2.3%, p=0.09). At 8-
year follow-up, Kaplan-Meier-estimated survival (74% vs 59%, p=0.03) and
Kaplan-Meier-estimated event-free survival (all cause deaths, myocardial
infarction, stroke, target vessel revascularization, heart failure (62% vs 41%,
p<0.01) were significantly higher in the BIMA group compared with the
LIMA-SVG group in an unmatched group comparison. The propensity score
matching analysis revealed that BIMA grafting is a safe revascularization pro-
cedure without long term survival difference in comparison with LIMA-SVG
use. Despite the absence of statistical significance, our analysis showed also
that BIMA grafting provides a favorable trend in terms of longer event-free
survival (p=0.11).
Conclusion: Our longitudinal analysis demonstrates that BIMA grafting
can be performed with acceptable perioperative mortality and suggests that
this surgical strategy could represent a powerful tool to improve the long-term
results in this high-risk group
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Is the euroscore II reliable to estimate operative mortality of valvular
surgery?
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Alkhoder (3), Marie-Pierre Dilly (2), Dominique Himbert (1), Richard
Raffoul (3), Patrick Nataf (3), Alec Vahanian (1)
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Purpose: Concerns have been raised regarding the reliability of the logistic
Euroscore (Euroscore I). The Euroscore II has been recently described to
achieve a more accurate prediction of operative mortality. However its perfor-
mance has not been specifically studied in valvular surgery. 
Methods: The predictive performance of the Euroscore I and II was compared
in 2859 consecutive patients who underwent valvular surgery in our institution
between 2006 and 2010. Discrimination was assessed using the c-index and cali-
bration by comparing predicted and observed mortality. 
Results: Mean age was 64±16 years, mean Euroscore I 8.6±9.6% and
mean Euroscore II 5.8±7.7%. Half of the patients underwent more than a
single valve procedure. Mortality at 30 days was 5.4% (154 patients). C-index
was 0.77 (95% CI 0.74-0.81) for the Euroscore I and 0.81 (95% CI 0.77-0.84)
for the Euroscore II. The overall comparison between predicted and observed
mortality showed a significant difference for the Euroscore I (p<0.0001),
whereas no difference was found for the Euroscore II (p=0.97). The Euroscore
I overestimated operative mortality, in particular in patients at intermediate
and high risk for surgery (Figure). 
Conclusion: The Euroscore II achieves a good predictive performance in
the estimation of 30-day mortality after valvular surgery. Calibration is mark-
edly improved as compared with the Euroscore I. These results support the use
of the Euroscore II for valvular surgery.
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Antidepressant therapy in patients undergoing CABG (MOTIV-CABG
trial): a prospective randomized double-blind placebo-controlled trial
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trie, Besançon, France – (3) Université Paris 13, Unité Transversale de
Recherches: Psychogénèse et psychopathologie EA 4403, Villetaneuse,
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Objectives: The efficacy of antidepressant therapy in patients undergoing
coronary artery bypass grafting (CABG) is not clearly established. 
Methods: This double-blind trial was conducted at University Hospital,
Besançon, France. Adult CABG patients were randomized (1:1) to receive
escitalopram (10 mg daily) or placebo from 2-3 weeks before to 6 months
after surgery, including 12 months post-surgery follow-up. The primary
composite endpoint was the occurrence of mortality or predefined morbidity
events. Secondary endpoints included measures of depression, mental and
physical health using Beck Depression Inventory Short Form (BDI) and
quality of life SF-36 self-assessments.
Results: The intention-to-treat cohort contained 361 patients with mean
age 67 years. At 12 months, the proportions of patients with the composite
morbidity/mortality endpoint were not different between escitalopram and pla-
cebo (110/182[60.4%] versus 108/179[60.3%], p=0.984). However, over the
6 months postoperative period, the BDI and SF-36 Mental Component Sum-
mary scores were better overall in the escitalopram group than in the placebo
group for all patients (p=0.015 and p=0.014, respectively) and preoperatively-
depressed (BDI>3) patients (p=0.002 and p=0.005, respectively). Moreover,
the SF-36 Pain score was better overall in the escitalopram group than in the
placebo group in the preoperatively-depressed subset (p=0.026).
Conclusions: Antidepressant therapy had no effect on morbidity and mor-
tality events up to 1 year after CABG. However, antidepressant therapy may
provide faster improvements to mental health aspects of quality of life and
reduce postoperative pain in patients with preoperative depression. Subject to
contra-indications, we recommend antidepressant therapy in coronary revascu-
larization patients who are preoperatively-depressed.
